Product Information
IRBESARTAN 300 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.1555 per EA under NDC 29300021419. Its NADAC has been published 117 times since May 29, 2024.
FDA first approved this application on Dec 7, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300021419
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IRBESARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203020FDA Approved
12/7/2015
TE Code
AB
On Market Since
12/7/2015
Pharmacological Classes
Price Statistics
The NADAC for IRBESARTAN 300 MG TABLET has been published 117 times since May 29, 2024, and over the history we have for it it has risen 5.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1555 per EA |
|---|---|
| All-time high | $0.2077 (Sep 11, 2024) |
| All-time low | $0.1461 (Feb 18, 2026) |
| 52-week high | $0.1597 |
| 52-week low | $0.1461 |
| Median price | $0.1561 |
| Average price | $0.1665 |
| Largest weekly change | +33.1% (Aug 21, 2024) |
| Weeks tracked | 117 |
| Tracking since | May 29, 2024 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of IRBESARTAN 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for IRBESARTAN 300 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.1555 per EA (NDC 29300021419), effective Aug 19, 2026.
How has the price of IRBESARTAN 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for IRBESARTAN 300 MG TABLET has risen 5.1%. It has been tracked across 117 weekly CMS publications since May 29, 2024.
What are the highest and lowest recorded NADAC prices for IRBESARTAN 300 MG TABLET?
Since May 29, 2024, the NADAC for IRBESARTAN 300 MG TABLET has ranged from a low of $0.1461 (Feb 18, 2026) to a high of $0.2077 (Sep 11, 2024), with a median of $0.1561 per EA.
Are there cheaper alternatives to IRBESARTAN 300 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IRBESARTAN 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures IRBESARTAN 300 MG TABLET?
IRBESARTAN 300 MG TABLET (NDC 29300021419) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.